Avacta Therapeutics
  • About
  • Our Science
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact
  • About
    • About Avacta
    • Leadership
    • Scientific Resources
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • Leadership
    • Scientific Resources
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
Home News
filter by: view all | Blogs | Diagnostics | Investors | Podcasts and Videos | R&D Spotlights Series | Therapeutics

News

28 Feb 2024

Proposed Fundraise to progress Therapeutics Division pipeline

Investors
11 Feb 2024

International Day of Women and Girls in Science

Blogs
22 Jan 2024

Issue of Equity and Total Voting Rights

Investors
19 Jan 2024

Appointment of Christina Coughlin, M.D., Ph.D. as Head of Research and Development

Investors | Therapeutics
19 Dec 2023

Appointment of Chief Business Officer

Investors | Therapeutics
13 Dec 2023

ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data

Investors | Therapeutics
04 Dec 2023

Shareholder update to review AVA6000 Phase 1a data

Investors | Therapeutics
15 Nov 2023

Affimer® biotherapeutics: The next generation of cancer therapies

Blogs | Therapeutics
23 Oct 2023

Issue of Equity and Total Voting Rights

Investors
20 Oct 2023

International Conference on Molecular Targets and Cancer Therapeutics, overview

Blogs

Posts navigation

Older posts
Newer posts
Avacta Therapeutics
  • Diagnostics
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Corporate Responsibility
  • Contact Us

Avacta Group plc

Scale Space,  White City
Imperial College Campus
58 Wood Lane
London
W12 7RZ

+44 (0)20 3911 0353

Investor Enquiries

ICR Consilium
85 Gresham Street
London
EC2V 7NQ

 

Email

Twitter | Linkedin

©2025 Avacta Therapeutics. Registered company no. 06605196.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok